Overview Pharmacokinetic Study of Testosterone Status: Completed Trial end date: 0000-00-00 Target enrollment: Participant gender: Summary Evaluation of pharmacokinetic and safety profile of testosterone after a single dose using auto-injector Phase: Phase 1 Details Lead Sponsor: Antares Pharma Inc.Treatments: MethyltestosteroneTestosteroneTestosterone 17 beta-cypionateTestosterone enanthateTestosterone undecanoate